XML 80 R65.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Proforma Condensed Balance Sheet (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Current Assets      
Cash $ 5,032,890 [1] $ 3,035,321  
Accounts receivable 18,446,176 18,043,235  
Prepayments and other current assets 253,779 3,834,585  
Total current assets 23,732,845 26,714,989  
Property, plant and equipment, net 394,090 122,326  
Right-of-use lease assets, net 341,625 155,323  
Deferred offering costs 1,128,453 [2]  
Total assets 25,597,013 26,992,638  
Current liabilities      
Accounts payable 12,652,514 18,297,191  
Taxes payable 244,096 98,417  
Accrued expenses and other current liabilities 125,701 [3] 47,459  
Derivative liabilities 109,346  
Short-term lease liabilities 124,095 72,730  
Total current liabilities 13,255,752 18,515,797  
Long-term lease liabilities 229,076 49,656  
Total liabilities 13,484,828 18,565,453  
Commitment and contingencies  
Shareholders’ equity:      
Ordinary shares, $0.0001 par value, 500,000,000 shares authorized, 21,250,000 shares issued and outstanding as on an actual basis, 25,000,000 issued and outstanding on a pro forma as adjusted basis [4] 2,125 2,125  
Additional paid-in capital 488,198 [5] 488,198  
Retained earnings 11,621,862 7,936,862  
Total shareholders’ equity 12,112,185 8,427,185 $ 4,858,217
Total liabilities and shareholders’ equity 25,597,013 $ 26,992,638  
Pro Forma [Member]      
Current Assets      
Cash [1] 20,032,890    
Accounts receivable 18,446,176    
Prepayments and other current assets 253,779    
Total current assets 38,732,845    
Property, plant and equipment, net 394,090    
Right-of-use lease assets, net 341,625    
Deferred offering costs [2]    
Total assets 39,468,560    
Current liabilities      
Accounts payable 12,652,514    
Taxes payable 244,096    
Accrued expenses and other current liabilities [3] 1,948,948    
Derivative liabilities 109,346    
Short-term lease liabilities 124,095    
Total current liabilities 15,078,999    
Long-term lease liabilities 229,076    
Total liabilities 15,308,075    
Commitment and contingencies    
Shareholders’ equity:      
Ordinary shares, $0.0001 par value, 500,000,000 shares authorized, 21,250,000 shares issued and outstanding as on an actual basis, 25,000,000 issued and outstanding on a pro forma as adjusted basis 2,500    
Additional paid-in capital [5] 12,536,123    
Retained earnings 11,621,862    
Total shareholders’ equity 24,160,485    
Total liabilities and shareholders’ equity $ 39,468,560    
[1] Pro forma cash reflects $15,000,000 offering proceeds.
[2] Pro forma deferred offering costs reflect charged against the gross proceeds of the offering.
[3] Pro forma accrued expenses and other current liabilities reflect $1,200,000 of underwriting discount and additional offering expenses of $623,247.
[4] Gives retroactive effect to reflect the reorganization in August 2022.
[5] Pro forma additional paid in capital reflect the net proceeds the Company expects to receive, after deducting underwriting fee, underwriters’ expense allowance and other expenses. The Company expects to receive net proceeds of $12,048,300 ($15,000,000 offering gross proceeds, less underwriting discounts of $1,200,000, and estimated offering expenses of $1,751,700).